Horizon

Horizon is a cell engineering company that provides gene editing, modulation and screening services for research and clinical applications.

Business Model:

Revenue: $76.4M

Employees: 201-500

Detailed Horizon Information

Horizon was acquired by PerkinElmer.
The acquisition happend on 2020-11-02.
Details of the transaction were not public

Acquirer

Geographic Data

Horizon headquarters map

Address: 8100 Cambridge Research Park

City: Cambridge

State: england

Zip: CB25 9TL

Country: GB

Financial Info

Stage:

post ipo equity

Raised Last:

$0

Raised Total:

$21M

Metrics

814,071Website Global Rank

47,662Website Monthly Traffic

Twitter Followers

Description

Horizon is a cell engineering company that provides gene editing, modulation and screening services for research and clinical applications.

Contact Phone:

Contact Email:

Horizon went public on 3/28/2014 on the London Stock Exchange

Listed Exchange:
London Stock Exchange

IPO Date:
3/28/2014

Ticker Symbol:
HZD

Amount Raised:
$114M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
7/2017 Sphere Fluidics Grant 0
7/2017 Sphere Fluidics Grant 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2010 Venture Round 3 $9.8M Roche Venture Fund
Jonathan Milner
David Evans
9/2011 Series C 7 $17.9M MVM Life Science Partners
Roche Venture Fund
Providence Investment Company Limited
Molten Ventures
Jonathan Milner
David Evans
David Cleevely
MVM Life Science Partners
Roche Venture Fund
Providence Investment Company Limited
Molten Ventures
Jonathan Milner
David Evans
David Cleevely
10/2013 Non Equity Assistance 1 - Future Fifty
Future Fifty
Future Fifty
Future Fifty
9/2018 Post-IPO Equity - ValueAct Capital
ValueAct Capital
ValueAct Capital
ValueAct Capital
4/2008 Series A 1 $298k University of Cambridge Enterprise
9/2018 Equity -
6/2013 Venture Round 11 $10.6M Peter Collins
Jonathan Milner
Parkwalk Advisors
Calculus Capital
Molten Ventures
Providence Investment Company Limited
Wren Capital
MVM Life Science Partners
Jonathan Milner
University of Cambridge Enterprise
Roche Venture Fund
David Evans
Peter Collins
Jonathan Milner
Parkwalk Advisors
Calculus Capital
Molten Ventures
Providence Investment Company Limited
Wren Capital
MVM Life Science Partners
Jonathan Milner
University of Cambridge Enterprise
Roche Venture Fund
David Evans
9/2011 Unattributed $11.1M
9/2018 Equity - ValueAct Capital
ValueAct Capital
9/2018 Post-IPO Equity 1 - ValueAct Capital
ValueAct Capital
ValueAct Capital
ValueAct Capital
10/2013 Non Equity Assistance 1 - Future Fifty
Future Fifty
Future Fifty
Future Fifty
6/2013 Venture Round 11 $10.6M Peter Collins
Jonathan Milner
Parkwalk Advisors
Calculus Capital
Molten Ventures
Providence Investment Company Limited
Wren Capital
MVM Life Science Partners
Jonathan Milner
Peter Collins
Jonathan Milner
Parkwalk Advisors
Calculus Capital
Molten Ventures
Providence Investment Company Limited
Wren Capital
MVM Life Science Partners
Jonathan Milner
9/2011 Series C 7 $17.9M MVM Life Science Partners
MVM Life Science Partners
Announced Date Name Price
7/2017 Dharmacon
1/2015 Haplogen Genomics GmbH
9/2014 SAGE Labs
6/2014 CombinatoRx
5/2010 Horizon Discovery Services Ltd.

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research